NSCLC patients with FAT1 mutation exhibited increased M1 macrophage infiltration, decreased M2 macrophage and T‐regulatory cell infiltration, along significantly elevated activated dendritic cells in FAT1‐mutated LUAD patients.42, 52. This evidence concerns the gene FAT1 and non-small cell lung carcinoma.